type 2 diabetes mellitus, impaired glucose tolerance
Conditions
Interventions
Medication adherence consultation and lifestyle guidance by pharmacists with three-month self-management using application (GlucoNotePlus) The consultation will be provided onece to twice per each pa
Sponsors
Department of Healthcare Information Management, The University of Tokyo Hospital
Nihon Chouzai Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Type 2 diabetes patients 2) more than 20 years old 3) patients who prescripts internal medicine for diabetes 4) Patients who can use iPhone (iOS 9.0 later) 5) Patients who can use GlucoNotePlus and Okusuritecho Plus 6) Patients who can visit same pharmacy (Nihon Chouzai Co., Ltd.) 7) Patients who provided written informed consent.
Exclusion criteria
Exclusion criteria: 1) patients with insulin therapy 2) patients with diabetic nephropathy 3) Patients with mental illness. 4) Patients with pacemakers. 5) Patients who are enrolled in other clinical trials. 6) Patients who have/had moderate to severe (requiring medical care) heart disease. 7) Patients who have moderate to severe (unstable condition) autoimmune disease, liver disease, digestive disorder, and/or respiratory disease. 8) Patients who are unable to exercise. 9) Patients who are under special dietary therapy (e.g. protein restriction, potassium restriction).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare HbA1c levels between at the start and the end of the study (after 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare medication adherence rate (MMAS-8), BMI, weight, steps, blood glucose, blood pressure and dietary contents between at the start and the end of the study (after 3 months) | — |
Countries
Japan
Contacts
Public ContactKayo Waki
the University of Tokyo Department of Healthcare Information Management, The University of Tokyo Hospital
Outcome results
None listed